15th Feb 2011 16:14
TR-1:- NOTIFICATION OF MAJOR INTEREST IN SHARES | |||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | CONSORT MEDICAL PLC | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | X | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to thenotification obligation: iii | Schroders plc | ||||
4. Full name of shareholder(s) (if different from 3.):iv | |||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 11.02.11 | ||||
6. Date on which issuer notified: | 14.02.11 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | 15%-14% | ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
Ordinary | 5,241,634 | 4,351,634 | 5,226,634 | N/A | 4,336,634 | N/A | 14.982% | |||||||||
GB0000946276 | ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
4,336,634 | 14.982% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
Schroder Investment Management Limited 4,001,947 13.826% Schroder Investment Management North America Limited 334,687 1.156%
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: | The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements.
Figures are based on a total number of voting rights of 28,945,789
| |
14. Contact name: | Michelle Palmer
| |
15. Contact telephone number: | 01442 867920
| |
Related Shares:
CSRT.L